Healthpeak Properties, Inc. financial data

Symbol
DOC on NYSE
Industry
Real Estate Investment Trusts
Location
4600 South Syracuse Street, Suite 500, Denver, CO
State of incorporation
MD
Fiscal year end
December 31
Former names
HCP, INC. (to 10/1/2019), HEALTH CARE PROPERTY INVESTORS INC (to 9/10/2007)
Latest financial report
10-K - Q4 2024 - Feb 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 125 % -4.97%
Return On Equity 2.61 % -40.1%
Return On Assets 1.21 % -38.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 700M shares +27.9%
Common Stock, Shares, Outstanding 699M shares +27.8%
Entity Public Float 11.8B USD +28.3%
Common Stock, Value, Issued 699M USD +27.8%
Weighted Average Number of Shares Outstanding, Basic 676M shares +23.5%
Weighted Average Number of Shares Outstanding, Diluted 676M shares +23.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.7B USD +23.8%
Revenue from Contract with Customer, Excluding Assessed Tax 568M USD +7.79%
General and Administrative Expense 97.2M USD +2.13%
Costs and Expenses 2.67B USD +36%
Nonoperating Income (Expense) 238M USD +155%
Income Tax Expense (Benefit) 4.35M USD -18.3%
Net Income (Loss) Attributable to Parent 243M USD -20.5%
Earnings Per Share, Basic 0.36 USD/shares -35.7%
Earnings Per Share, Diluted 0.36 USD/shares -35.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 120M USD +1.86%
Operating Lease, Right-of-Use Asset 424M USD +76.6%
Intangible Assets, Net (Excluding Goodwill) 817M USD +160%
Goodwill 68.5M USD +280%
Assets 19.9B USD +27%
Liabilities 10.9B USD +24%
Accumulated Other Comprehensive Income (Loss), Net of Tax 28.8M USD +48.8%
Stockholders' Equity Attributable to Parent 8.4B USD +32.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 9.06B USD +31.7%
Liabilities and Equity 19.9B USD +27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 153M USD -12.3%
Net Cash Provided by (Used in) Financing Activities -66.6M USD +72.2%
Net Cash Provided by (Used in) Investing Activities -97.8M USD -274%
Common Stock, Shares Authorized 1.5B shares +100%
Common Stock, Shares, Issued 699M shares +27.8%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.9M USD -23.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 184M USD +9.04%
Interest Paid, Excluding Capitalized Interest, Operating Activities 73.8M USD +12.9%
Deferred Tax Assets, Valuation Allowance 2.31M USD -82.3%
Deferred Tax Assets, Gross 166M USD -3.13%
Operating Lease, Liability 307M USD +48.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 253M USD -15%
Lessee, Operating Lease, Liability, to be Paid 834M USD +53.9%
Property, Plant and Equipment, Gross 38M USD -2.56%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.4M USD +48.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 21.5M USD +26.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +23.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 527M USD +57.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.4M USD +49.6%
Deferred Tax Assets, Operating Loss Carryforwards 50M USD -7.56%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.5M USD +50.1%
Additional Paid in Capital 12.8B USD +23.5%
Deferred Tax Assets, Net of Valuation Allowance 163M USD +3.38%
Interest Expense 280M USD +40%